Response by Bai et al to Letter Regarding Article, “Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis”

DOI: 10.1161/STROKEAHA.117.017460

Issn Print: 0039-2499

Publication Date: 2017/06/01

Ying Bai; Alena Shantsila; Gregory Y.H. Lip


		Checking for direct PDF access through Ovid

Abstract unavailable for this article.


		Loading Related Articles